Glutathione S-transferase M1 genotypes and the risk of vulvar cancer: A population-based case-control study

American Journal of Epidemiology

Volumn 150, Issue 5, 1999, Pages 437-442

  Chen, Chu ^a   Madeleine, Margaret M ^a   Weiss, Noel S ^a,b   Daling, Janet R ^a,b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Case control studies; Genetic predisposition to disease; Glutathione transferase; Polymorphism (genetics); Vulvar neoplasms

Indexed keywords

CARCINOGEN; GLUTATHIONE TRANSFERASE;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CANCER RISK; CASE CONTROL STUDY; CIGARETTE SMOKING; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; POPULATION RESEARCH; UNITED STATES; VULVA CANCER;

EID: 0033198960     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.aje.a010031     Document Type: Article

References (54)

1. Newcomb PA, Weiss NS, Daling JR. Incidence of vulvar carcinoma in relation to menstrual, reproductive, and medical factors. J Natl Cancer Inst 1984;73:391-6.
2. Daling JR, Sherman KJ, Hislop TG, et al. Cigarette smoking and the risk of anogenital cancer. Am J Epidemiol 1992;135: 180-9.
3. Brinton LA, Nasca PC, Mallin K, et al. Case-control study of cancer of the vulva. Obstet Gynecol 1990;75:859-66.
4. Madeleine MM, Daling JR, Carter JJ, et al. Cofactors with human papillomavirus in a population-based study of vulvar cancer. J Natl Cancer Inst 1997;89:1516-23.
5. Polynuclear aromatic compounds, Part 1, Chemical, environmental and experimental data. IARC Monogr Eval Carcinog Risk Chem Hum 1983;32:1-453.
6. Yamashita M, Wakabayashi K, Nagao M, et al. Detection of 2-amino-3-metnylimidazo[4,5-f]quinoline in cigarette smoke condensate. Jpn J Cancer Res 1986;77:419-22.
7. 32P postlabelling analysis of urinary mutagens from smokers of black tobacco implicates 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) as a major DNA-damaging agent. Carcinogenesis 1991;12:713-17.
8. Hoffmann D, Hecht SS. Nicotine-derived N-nitrosamines and tobacco-related cancer: current status and future directions. (Review). Cancer Res 1985;45:935-44.
9. Smith MT, Evans CG, Doane-Setzer P, et al. Denitrosation of 1,3-bis(2-chloroethyl)-1-nitrosourea by class mu glutathione transferases and its role in cellular resistance in rat brain tumor cells. Cancer Res 1989;49:2621-5.
10. Robertson IGC, Guthenberg C, Mannervik B, et al. Differences in stereoselectivity and catalytic efficiency of three human glutathione transferases in the conjugation of glutathione with 7beta;,8α-dihydroxy-9α,10α-oxy-7,8,9,10-tetrahydrobenzo(a) pyrene. Cancer Res 1986;46:2220-4.
11. Board PG. A method for the localization of glutathione S-transferase isozymes after starch gel electrophoresis. Anal Biochem 1980;105:147-9.
12. Board PG. Biochemical genetics of glutathione-S-transferase in man. Am J Hum Genet 1981;33:36-43.
13. Seidegard J, Pero RW. The hereditary transmission of high glutathione transferase activity towards tras-stilbene oxide in human mononuclear leukocytes. Hum Genet 1985;69:66-8.
14. Lin HJ, Han CY, Bernstein DA, et al. Ethnic distribution of the glutathione transferase Mu 1-1 (GSTM1) null genotype in 1473 individuals and application to bladder cancer susceptibility. Carcinogenesis 1994;15:1077-81.
15. Hartge P, Brinton LA, Rosenthal JF, et al. Random digit dialing in selecting a population-based control group. Am J Epidemiol 1984;120:825-33.
16. Chen C, Madeleine MM, Lubinski C, et al. Glutathione S-transferase M1 genotypes and the risk of anal cancer: a population-based case-control study. Cancer Epidemiol Biomarkers Prev 1996;5:985-91.
17. Tobacco smoking. IARC Monogr Eval Carcinog Risk Chem Hum 1986;38:35-394.
18. Hecht SS, Hoffmann D. Tobacco-specific nitrosamines, an important group of carcinogens in tobacco and tobacco smoke. (Review). Carcinogenesis 1988;9:875-84.
19. Crespi CL, Penman BW, Gelboin HV, et al. A tobacco smoke-derived nitrosamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, is activated by multiple human cytochrome P450s including the polymorphic human cytochrome P4502D6. Carcinogenesis 1991;12:1197-201.
20. Hoffmann D, Brunnemann KD, Prokopczyk B, et al. Tobacco-specific N-nitrosamines and Areca-derived N-nitrosamines: chemistry, biochemistry, carcinogenicity, and relevance to humans. (Review). J Toxicol Environ Health 1994;41:1-52.
21. Simons AM, Phillips DH, Coleman DV. Damage to DNA in cervical epithelium related to smoking tobacco. BMJ 1993;306:1444-8.
22. Kadlubar FF, Badawi AF. Genetic susceptibility and carcinogen-DNA adduct formation in human urinary bladder carcinogenesis. Toxicol Lett 1995;82-83:627-32.
23. Kaderlik KR, Kadlubar FF. Metabolic polymorphisms and carcinogen-DNA adduct formation in human populations. Pharmacogenetics 1995;5(spec no.):S108-17.
24. Page JE, Ross HL, Bigger CAH, et al. Mutagenic specificities and adduct distributions for 7-bromomethylbenz(a)anthracenes. Carcinogenesis 1996;17:283-8.
25. Nesnow S, Davis C, Nelson G, et al. Comparison of the morphological transforming activities of dibenzo[a,l]pyrene and benzo[a]pyrene in C3H10T1/2CL8 cells and characterization of the dibenzo[a,l]pyrene-DNA adducts. Carcinogenesis 1997; 18:1973-8.
26. Prahalad AK, Ross JA, Nelson GB, et al. Dibenzo[a,l]]pyrene-induced DNA adduction, tumorigenicity, and Ki-ras oncogene in strain A/J mouse lung. Carcinogenesis 1997;18:1955-63.
27. Yang SK, McCourt DW, Leutz JC, et al. Benzo[a]pyrene diol epoxides: mechanism of enzymatic formation and optically active intermediates. Science 1977;196:1199-201.
28. Seidegard J, De Pierre JW, Birberg W, et al. Characterization of soluble glutathione transferase activity in resting mononuclear leukocytes from human blood. Biochem Pharmacol 1984;33:3053-8.
29. Shields PG, Bowman ED, Harrington AM, et al. Polycyclic aromatic hydrocarbon-DNA adducts in human lung and cancer susceptibility genes. Cancer Res 1993;53:3486-92.
30. Ryberg D, Hewer A, Phillips DH, et al. Different susceptibility to smoking-induced DNA damage among male and female lung cancer patients. Cancer Res 1994;54:5801-3.
31. Kato S, Bowman ED, Harrington AM, et al. Human lung carcinogen-DNA adduct levels mediated by genetic polymorphisms in vivo. J Natl Cancer Inst 1995;87:902-7.
32. Nielsen PS, Depater N, Okkels H, et al. Environmental air pollution and DNA adducts in Copenhagen bus drivers - effect of GSTM1 and NAT2 genotypes on adduct levels. Carcinogenesis 1996;17:1021-7.
33. Ryberg D, Skaug V, Hewer A, et al. Genotypes of glutathione transferase M1 and P1 and their significance for lung DNA adduct levels and cancer risk. Carcinogenesis 1997;18: 1285-9.
34. Hou S-M, Lambert B, Hemminki K. Relationship between hprt mutant frequency, aromatic DNA adducts, and genotypes for GSTMI and NAT2 in bus maintenance workers. Carcinogenesis 1995;16:1913-17.
35. Rothman N, Shields PG, Poirier MC, et al. The impact of glutathione S-transferase M1 and cytochrome P450 1A1 genotypes on white-blood-cell polycyclic aromatic hydrocarbonDNA adduct levels in humans. Mol Carcinog 1995;14:63-8.
36. Seidegard J, Pero RW, Miller DG, et al. A glutathione transferase in human leukocytes as a marker for the susceptibility to lung cancer. Carcinogenesis 1986;7:751-3.
37. Zhong S, Howie AF, Ketterer B, et al. Glutathione S-transferase mu locus: use of genotyping and phenotyping assays to assess association with lung cancer susceptibility. Carcinogenesis 1991;12:1533-7.
38. Heckbert SR, Weiss NS, Hornung SK, et al. Glutathione S-transferase and epoxide hydrolase activity in human leukocytes in relation to risk of lung cancer and other smoking-related cancers. J Natl Cancer Inst 1992;84:414-22.
39. Hirvonen A, Husgafvel-Pursiainen K, Anttila S, et al. The GSTM1 null genotype as a potential risk modifier for squamous cell carcinoma of the lung. Carcinogenesis 1993;14: 1479-81.
40. Nazar-Stewart V, Motulsky AG, Eaton DL, et al. The glutathione S-transferase mu polymorphism as a marker for susceptibility to lung carcinoma. Cancer Res 1993;53(suppl):2313-18.
41. Alexandrie AK, Sundberg MI, Seidegard J, et al. Genetic susceptibility to lung cancer with special emphasis on CYP1A1 and GSTM1: a study on host factors in relation to age at onset, gender and histological cancer types. Carcinogenesis 1994; 15:1785-90.
42. Bell DA, Taylor JA, Paulson DF, et al. Genetic risk and carcinogen exposure: a common inherited defect of the carcinogen-metabolism gene glutathione S-transferase M1 (GSTM1) that increases susceptibility to bladder cancer. J Natl Cancer Inst 1993;85:1159-64.
43. Daly AK, Thomas DJ, Cooper J, et al. Homozygous deletion of gene for glutathione S-transferase M1 in bladder cancer. BMJ 1993;307:481-2.
44. Lafuente A, Pujol F, Carretero P, et al. Human glutathione S-transferase mu (GST mu) deficiency as a marker for the susceptibility to bladder and larynx cancer among smokers. Cancer Lett 1993;68:49-54.
45. Brockmoller J, Kerb R, Drakoulis N, et al. Glutathione S-transferase M1 and its variants A and B as host factors of bladder cancer susceptibility: a case-control study. Cancer Res 1994;54:4103-11.
46. Zhong S, Wyllie AH, Barnes D, et al. Relationship between the GSTM1 genetic polymorphism and susceptibility to bladder, breast, and colon cancer. Carcinogenesis 1993;14:1821-4.
47. Brockmoller J, Kerb R, Drakoulis N, et al. Genotype and phenotype of glutathione S-transferase class mu isoenzymes mu and psi in lung cancer patients and controls. Cancer Res 1993; 53:1004-11.
48. London SJ, Daly AK, Cooper J, et al. Polymorphism of glutathione S-transferase M1 and lung cancer risk among African-Americans and Caucasians in Los Angeles County, California. J Natl Cancer Inst 1995;87:1246-53.
49. Szarka CE, Pfeiffer GR, Hum ST, et al. Glutathione S-transferase activity and glutathione S-transferase mu expression in subjects with risk for colorectal cancer. Cancer Res 1995;55: 2789-93.
50. Lin HJ, Probst-Hensch NM, Ingles SA, et al. Glutathione transferase (GSTM1) null genotype, smoking, and prevalence of colorectal adenomas. Cancer Res 1995;55:1224-6.
51. Sherman KJ, Daling JR, Chu J, et al. Genital warts, other sexually transmitted diseases, and vulvar cancer. Epidemiology 1991;2:257-62.
52. Hildesheim A, Han CL, Brinton LA, et al. Human papillomavirus type 16 and risk of preinvasive and invasive vulvar cancer - results from a seroepidemiological case-control study. Obstet Gynecol 1997;90:748-54.
53. van Bladeren PJ, Breimer DD, Rotteveel-Smijs GM, et al. The activating role of glutathione in the mutagenicity of 1,2-dibromoethane. Adv Exp Med Biol 1981;136:809-20.
54. 7-guanyl)ethyl]glutathione, the major DNA adduct formed from 1,2-dibromoethane. Biochemistry 1986;25:2192-8.